0.145High0.145Low3.68MVolume0.145Open0.145Pre Close532.88KTurnover0.15052wk High0.00%Turnover Ratio0Shares0.14052wk Low--EPS TTM0Float Cap0.150Historical High--P/E (Static)0Shs Float0.140Historical Low--EPS LYR0.00%Amplitude--Dividend TTM--P/B100Lot Size--Div YieldTTM
2.6% of cw has been converted to ordinary shares in 2 months, bringing RM 1.9million cash to sunzen. the intention to reach 500 million capital is very obvious, they will use this money to carry another M&A , since floating cw getting lesser, i guess cw will move faster in the future.
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
$SUNZEN(0148.MY)$
Sunzen Biotech Berhad has undergone significant business transformation and growth in recent years. Here are some key investment highlights to help you better understand the future prospects of this company.
Exiting from Animal Health Business. As of the latest record (FY2022), the animal health business accounted for 6.01% of the annual revenue but incurred a pre-tax loss of RM4.67 millio...
they not only want more M&A,they want the best M&A. they will be more famous,benefit ecolite brands ,attract more investor
maybe is time to add some cw,is going to be dinosour soon
they try very hard to expand nosh to reach bursa requirement?more than 2% cw had converted to ordianaryshares
to transfer to main board,sunzen need expand capital to 500m,with the NOSH up to 801m,sunzen share price must maintain above 0.63. since sunzen target to be listed in main board next year,to fulfill bursa requirements,this stock must double its share price in 12 months.
the conversion of wc to ordianary shares will help sunzen increase NOSH ,thus is much easier to achive 500m cap,that is why recently, 2% of wc had been converted to ordinary shares.
the conversion of wc may co...
No comment yet